# A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)

> **NCT01977573** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 252 (actual)

## Conditions studied

- Anaemia

## Interventions

- **DRUG:** GSK1278863
- **DRUG:** rhEPO

## Key facts

- **NCT ID:** NCT01977573
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10-31
- **Primary completion:** 2015-05-01
- **Final completion:** 2015-06-15
- **Target enrollment:** 252 (ACTUAL)
- **Last updated:** 2018-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01977573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01977573, "A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01977573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*